The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma
Abstract The management of metaplastic breast carcinoma (MBC) has largely paralleled the paradigms used for invasive ductal carcinoma (IDC) in the current National Comprehensive Cancer Network guidelines of breast cancer. However, patients with IDC and MBC have been shown to have a different prognos...
Guardado en:
Autores principales: | San-Gang Wu, Shi-Ping Yang, Wen-Wen Zhang, Jun Wang, Chen-Lu Lian, Yong-Xiong Chen, Zhen-Yu He |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d01d86d50564ea6b958c0cc58461fcf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Willard Wong, et al.
Publicado: (2021) -
Metaplastic breast carcinoma with upper limb gangrene
por: Rajan R, et al.
Publicado: (2017) -
A Risk Model based on Ultrasound, Ultrasound Elastography, and Histologic Parameters for Predicting Axillary Lymph Node Metastasis in Breast Invasive Ductal Carcinoma
por: Xiao-Long Li, et al.
Publicado: (2017) -
IMMUNOHISTOCHEMICAL EXPRESSION OF P53 IN INVASIVE DUCTAL CARCINOMA OF BREAST IN PAKISTANI WOMEN
por: Umair Aslam Shahzad khan, et al.
Publicado: (2021) -
Similar prognoses for invasive micropapillary breast carcinoma and pure invasive ductal carcinoma: a retrospectively matched cohort study in China.
por: Yin Liu, et al.
Publicado: (2014)